WebDoctor Encyclopedia

Cutaneous sarcomas

Atypical fibroxanthoma (AFX)

Atypical fibroxanthoma (AFX) is an uncommon, fast-growing skin tumour that appears as a red lump on sun-damaged skin of the head and neck in older people. It looks aggressive under the microscope but rarely spreads and is usually cured by Mohs surgery or excision.

Medically reviewed Last reviewed October 19, 2026

What is atypical fibroxanthoma?

Atypical fibroxanthoma (AFX) is an uncommon skin tumour that usually appears as a fast-growing red lump on sun-damaged skin of the head and neck in older people, especially men.

Under the microscope, AFX looks alarming. Its cells are large, strange-shaped and dividing quickly, much like a high-grade sarcoma. Yet in practice it behaves in a low-grade way: it stays in the upper layer of the skin (the dermis), rarely spreads, and is cured by surgery in the vast majority of people (Fretzin and Helwig, 1973).

AFX is considered a superficial, low-grade cousin of pleomorphic dermal sarcoma (PDS). If a tumour with the same cells grows deeper into the fat under the skin, invades nerves or blood vessels or contains dead tissue, it is called PDS instead. PDS is more likely to come back and to spread (Soleymani et al., 2019).

The main cause is long-term sun exposure. The tumour cells carry the typical “fingerprint” of ultraviolet (UV) damage in their DNA. AFX is also more common in people with a weakened immune system, such as organ transplant recipients.

AFX is treated by removing it completely, often with Mohs micrographic surgery, which checks every edge under the microscope. After complete removal, the chance of it coming back is low (Tolkachjov et al., 2018).

1. Key facts at a glance

Feature Details
Type of tumour Superficial, low-grade mesenchymal (connective tissue) tumour of the skin
How common Uncommon; often listed among rare skin cancers
Typical age Usually over 70
Sex Much more common in men
Common sites Scalp, ears, cheeks, nose, neck, especially bald or sun-damaged skin
Appearance Fast-growing red or pink dome-shaped lump, often bleeding or ulcerated
Main cause Long-term UV (sun) damage
Main treatment Mohs surgery or wide local excision
Outlook Excellent; local recurrence uncommon, spread very rare

2. Causes and risk factors

Risk factor Notes
Long-term sun exposure The most important cause; AFX occurs mostly on sun-exposed skin
Older age Most people are in their 70s or 80s
Male sex Men are affected far more often
Fair skin Burns easily, tans poorly
Bald scalp Exposes the scalp to more UV light
Weakened immune system Organ transplant, chronic lymphocytic leukaemia, immunosuppressive medicines
Previous radiotherapy Rarely, AFX develops in skin treated with radiation
Other skin cancers Many people with AFX also have basal cell or squamous cell carcinomas

How common is it?

AFX is uncommon but not extremely rare. A population study in Olmsted County, Minnesota, found that it occurred mostly in older men and on the head and neck (Tolkachjov et al., 2017). It is seen regularly in dermatology and Mohs surgery clinics, especially in sunny countries such as Australia and the southern United States.

The number of cases is expected to rise as populations age, because AFX is so closely linked with a lifetime of sun exposure.

Gene changes

AFX cells contain many UV-related DNA changes, especially in the TP53 gene, which normally protects cells from becoming cancerous. Changes in genes such as TERT, CDKN2A and the RAS family are also common. These changes are acquired through sun damage and are not inherited.

AFX and pleomorphic dermal sarcoma

AFX and PDS are thought to be two ends of a single spectrum.

Feature AFX Pleomorphic dermal sarcoma
Depth Confined to the dermis; may just touch the upper fat Invades deeper into the fat, fascia or muscle
Necrosis (dead tissue) Absent May be present
Nerve or vessel invasion Absent May be present
Local recurrence Uncommon More common
Spread Very rare Occasional, to lymph nodes or lungs

The final diagnosis can only be made after the whole tumour is removed and examined, because a small biopsy cannot show how deep it goes.

3. How does it look

On the skin

Feature Description
Shape A firm, raised, dome-shaped lump (nodule)
Colour Red, pink or skin-coloured; sometimes with a shiny surface
Surface Smooth at first; may crust, ulcerate or bleed
Size Usually less than 2 cm
Growth Often grows over weeks to a few months
Surrounding skin Typically sun-damaged, with wrinkles, brown spots or rough patches

AFX can look very like squamous cell carcinoma, basal cell carcinoma, amelanotic melanoma or pyogenic granuloma. It cannot be diagnosed by eye alone.

Under the microscope

Feature Description
Cells Large, bizarre, pleomorphic cells; spindle-shaped and epithelioid cells; giant cells with several nuclei
Mitoses Many, including abnormal forms
Location Within the dermis, often close to the surface, with sun-damaged (elastotic) skin around it
Edges Usually fairly well defined
Absent features No deep invasion, no necrosis, no nerve or vessel invasion

Special stains

AFX is a diagnosis of exclusion. Pathologists use stains to rule out other cancers that can look identical (Iorizzo and Brown, 2011).

Stain Result in AFX Why it matters
Keratins and p40/p63 Negative Excludes spindle cell squamous cell carcinoma
SOX10, S100, Melan-A Negative Excludes melanoma
Desmin and other muscle markers Negative Excludes leiomyosarcoma
CD31, ERG Negative Excludes angiosarcoma
CD10, CD99, CD68 Often positive Support the diagnosis but are not specific

4. Symptoms

AFX usually causes few symptoms other than the lump itself.

Common symptoms

  • A new, quickly growing lump on the head, neck or another sun-exposed area
  • Bleeding after minor knocks, combing or shaving
  • Crusting or an open sore that does not heal
  • Tenderness or mild discomfort
  • Itching in some people

Symptoms that suggest a deeper or more aggressive tumour

Sign Possible meaning
Fixed, deeper lump Possible pleomorphic dermal sarcoma
Numbness or pain Possible nerve involvement
Lump returning after removal Local recurrence
Swollen lymph nodes in the neck Rare spread

When to seek medical advice

See a doctor or dermatologist about any skin lump that is new, growing quickly, bleeding or not healing within 3-4 weeks, especially on sun-damaged skin. Early removal means a smaller operation and a better result.

5. Diagnosis

Test Purpose
Skin examination and dermoscopy Assesses the lump and nearby skin
Skin biopsy Provides tissue for diagnosis; may be a shave, punch or excision biopsy
Immunohistochemistry Rules out squamous cell carcinoma, melanoma and other tumours
Complete removal and full examination Confirms AFX by showing the tumour is superficial
Lymph node examination Checks for swollen nodes
Imaging Usually not needed; used if PDS or spread is suspected

Why biopsy results can be confusing

A first biopsy report may say “atypical spindle cell tumour” or “pleomorphic dermal neoplasm” rather than giving a firm diagnosis. This is normal. The pathologist needs the whole tumour to measure its depth and check for features of PDS.

The final report after complete removal will state whether the tumour is AFX or PDS, whether the margins are clear, and whether any high-risk features were seen. Ask your doctor to explain these results, because they guide follow-up.

6. Treatment

Surgery

Surgery is the main and usually only treatment needed.

Approach Notes
Mohs micrographic surgery Removes the tumour layer by layer, checking 100% of the margin; spares healthy tissue on the face, ears and scalp
Wide local excision Removes the tumour with a margin of normal skin, usually about 1 cm
Skin graft or flap Used to close larger wounds

How Mohs surgery works

Step What happens
1. Numbing The area is numbed with a local anaesthetic injection
2. First layer The visible tumour is removed with a thin rim of skin
3. Mapping The tissue is marked and mapped so the surgeon knows its exact position
4. Microscope check The entire edge and base are examined while you wait
5. Further layers If tumour remains, another thin layer is taken only from that spot
6. Repair When the margins are clear, the wound is closed with stitches, a flap or a graft, or left to heal

A systematic review found that local recurrence was about 2% after Mohs surgery, compared with about 9% after standard excision (Tolkachjov et al., 2018).

Other treatments

Treatment When used
Radiotherapy For people who cannot have surgery, after incomplete removal, or for recurrent tumours
Re-excision When margins are not clear
Treatment for PDS Wider surgery, sometimes radiotherapy, and imaging to check for spread

Chemotherapy is not used for typical AFX.

Side effects

Treatment Possible side effects
Skin surgery Pain, bruising, swelling, scarring, wound infection, slow healing on the scalp
Skin graft Different colour or texture of skin; graft failure in a small number
Radiotherapy Skin redness, peeling, hair loss in the area, later skin thinning

What treatment involves day to day

Part of treatment What to expect
Mohs surgery Done under local anaesthetic as a day case; it may take several hours while each layer is checked
Standard excision Usually a short procedure under local anaesthetic
Wound care Dressings for 1-2 weeks; stitches removed after about 1 week on the face and 2 weeks on the scalp
Recovery Most people return to normal activities within days

7. Outlook (prognosis)

Measure Approximate outlook
Cure after complete removal Most people
Local recurrence Uncommon; about 2% after Mohs surgery and about 9% after excision
Spread (metastasis) Very rare for true AFX
Death from AFX Extremely rare

A large meta-analysis found that incomplete removal and features of PDS were the main risk factors for the tumour coming back or progressing (Ørholt et al., 2022). Most recurrences appear within the first 1-2 years and can usually be removed again (Polcz et al., 2018).

8. Follow-up

Follow-up Purpose
Skin checks Every 6 months for 1-2 years, then yearly
Scar examination To detect early recurrence
Full skin examination Many people have or develop other skin cancers
Lymph node check Particularly if PDS was suspected

9. Living with atypical fibroxanthoma

  • Protect your skin from the sun with hats, clothing, shade and broad-spectrum sunscreen
  • Wear a wide-brimmed hat if you have a bald or thinning scalp
  • Check your skin monthly, including the scalp and ears, with a mirror or a partner’s help
  • Report new or changing lumps without waiting for your next appointment
  • Tell your team if you take medicines that weaken the immune system
  • Look after the wound and keep it clean and covered until healed

Sun protection checklist

Tip Details
Seek shade Especially between 11:00 and 15:00 in summer
Cover up Wide-brimmed hat, long sleeves and sunglasses
Use sunscreen SPF 30 or higher, broad-spectrum, reapplied every 2 hours outdoors
Do not forget the ears and scalp These are common AFX sites
Avoid sunbeds They increase UV damage
Treat sun-damaged skin Ask your dermatologist about treating rough pre-cancerous patches (actinic keratoses)

10. Frequently asked questions

Question Answer
Is AFX cancer? It is a low-grade malignant tumour, but it behaves mildly and is usually cured by surgery
Is it a type of sarcoma? It is a mesenchymal tumour closely related to pleomorphic dermal sarcoma, but much less aggressive
Will I need chemotherapy? No
Can it come back? Occasionally, especially after incomplete removal
Is it caused by the sun? Mostly yes; UV damage is the main cause
Will it leave a scar? Yes, but Mohs surgery and careful reconstruction keep scars as small as possible
Can it spread? True AFX very rarely spreads
Why was a second operation needed? Sometimes the first biopsy or excision does not remove all the tumour, or the depth needs to be confirmed
Does having AFX mean I will get other skin cancers? Your risk of other sun-related skin cancers is higher, so regular skin checks are important

11. Questions to ask your care team

  • Was the tumour completely removed with clear margins?
  • Is it definitely AFX and not pleomorphic dermal sarcoma?
  • Would Mohs surgery be suitable for me?
  • Do I need any scans?
  • How often should I have skin checks?
  • Should I have treatment for other sun-damaged areas of my skin?
  • What signs of recurrence should I look for?

Resources

  1. Fretzin, D.F. and Helwig, E.B. (1973) ‘Atypical fibroxanthoma of the skin: a clinicopathologic study of 140 cases’, Cancer, 31(6), pp. 1541-1552.
  2. Iorizzo, L.J. and Brown, M.D. (2011) ‘Atypical fibroxanthoma: a review of the literature’, Dermatologic Surgery, 37(2), pp. 146-157.
  3. Ørholt, M. et al. (2022) ‘Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: a meta-analysis of individualized participant data’, Journal of Surgical Oncology, 126(3), pp. 555-562.
  4. Polcz, M.M., Sebaratnam, D.F. and Fernández-Peñas, P. (2018) ‘Atypical fibroxanthoma management: recurrence, metastasis and disease-specific death’, Australasian Journal of Dermatology, 59(1), pp. 10-25.
  5. Soleymani, T. et al. (2019) ‘Atypical fibroxanthoma and pleomorphic dermal sarcoma: updates on classification and management’, Dermatologic Clinics, 37(3), pp. 253-259.
  6. Tolkachjov, S.N. et al. (2017) ‘Incidence and clinical features of rare cutaneous malignancies in Olmsted County, Minnesota, 2000 to 2010’, Dermatologic Surgery, 43(1), pp. 116-124.
  7. Tolkachjov, S.N. et al. (2018) ‘Atypical fibroxanthoma: systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision’, Journal of the American Academy of Dermatology, 79(5), pp. 929-934.
  8. National Cancer Institute (2026) Skin Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/skin/hp/skin-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.